CLEO Further Expands Ovarian Cancer Trial with Siles Health
Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com
Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com
Gold saw incredible price gains in 2024, rising from US$2,000 per ounce to close to US$2,800. Various factors have lent support, including
The cryptocurrency market has experienced a remarkable transformation over the past year, marked by strong investor interest and a significant resurgence in
Boab Metals Limited (ASX: BML) (“Boab” or “Company”) is pleased to announce that its wholly owned subsidiary, Sorby Hills Pty Ltd (“SHPL”),
Zero Candida (the ‘Company’ or ‘ZC’) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received
Syntheia Corp. (“Syntheia” or the “Company”) (syntheia.ai), CSE – SYAI, a leading provider of conversational AI solutions for inbound telephone call management,
Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral
Trillion Energy International Inc. (‘ Trillion ‘ or the ‘Company ‘) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62), has reissued its consolidated financial
Riverside Resources Inc. (TSXV: RRI) (OTCQB: RVSDF) (FSE: 5YY) (‘Riverside’ or the ‘Company’), is pleased to announce it has signed an option agreement to
Lithium Universe (LU7:AU) has announced Supplementary Prospectus Download the PDF here. This post appeared first on investingnews.com